Digest Network Come funziona
Network
/
Società
AC
Non verificato

ACADIA Pharmaceuticals Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

69 comunicati stampa

Guarda tutti i comunicati
03/03/2026
Mercato del lavoro
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
02/03/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Psichiatria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
23/02/2026
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
04/02/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
02/02/2026
Industria
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
13/01/2026
Web e Social Network
Eventi
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
18/12/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
12/12/2025
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
20/11/2025
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0